To investigate NLRC4 and NLRP3 inflammasomes as potential prognostic markers in glioma patients, we compared NLRP3 (Fig. 2a) or NLRC4 (Fig. 2b) expression with survival using TCGA data. This evidence concerns the gene NLRC4 and glioma.